Roche Moves Future Germany Investments ‘on Hold’
8 Articles
8 Articles
Roche accuses the Federal Government of destroying confidence with short-term austerity measures. While the international growth path continues, new projects in Germany are on hold for the time being.
Roche moves future Germany investments ‘on hold’
FRANKFURT, Oct 19 (Reuters) - Swiss drugmaker Roche is reviewing all future investments in Germany over healthcare cost-cutting policies, the company's Germany chief said in an interview with newspaper Welt that was published on Monday. "We have put ...
Head of Roche Germany Daniel Steiners challenges future investments in Germany. He criticises the German government's austerity policy and calls for planning security.
The German government has destroyed trust, and the location is experiencing a break. Therefore, Roche, a pharmaceutical company, is stopping all investments in Germany for the time being.
Der Pharmakonzern Roche stellt alle Investitionen in Deutschland auf den Prüfstand. Im Interview spricht Deutschland-Chef Daniel Steiners über die politicsche
Roche, a pharmaceutical company, is putting all investments in Germany to the test. In an interview, Germany's CEO Daniel Steiners talks about the political gap that led to and when he would invest again.
Coverage Details
Bias Distribution
- 67% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
